Circulating Mitochondrial Open Reading Frame of the 12S Ribosomal RNA Type-c Is Higher in Acute Coronary Syndrome and

Pengyu Cao1,2, Bojian Wang3, Ningning Zhang2

  • 1Changzhou Medical Center Nanjing Medical University Changzhou 213004 Jiangsu China.

Insights

Mitochondrial open reading frame of the 12S ribosomal RNA type-c (MOTS-c) is elevated in acute coronary syndrome patients, correlating with oxidative stress. MOTS-c shows potential in predicting major adverse cardiac events, especially in myocardial infarction cases.

Area of Science:

  • Cardiology
  • Biochemistry
  • Molecular Biology

Background:

  • The role of MOTS-c in acute coronary syndrome (ACS) is largely unknown.
  • Oxidative stress is a key factor in cardiovascular disease pathogenesis.
  • Investigating novel biomarkers for ACS risk stratification is crucial.

Purpose of the Study:

  • To measure circulating MOTS-c levels in ACS patients.
  • To assess the relationship between MOTS-c, oxidative stress markers, and major adverse cardiac events (MACE).
  • To evaluate MOTS-c's predictive value for ACS and MACE.

Main Methods:

  • Serum MOTS-c and thiobarbituric acid reactive substances (TBARS) measured in 400 subjects (controls, unstable angina, acute myocardial infarction).
  • Clinical data, MACE, and 18-month follow-up were recorded.
  • In vitro studies examined MOTS-c's response to oxidative stress.

Main Results:

  • Elevated serum MOTS-c and TBARS in ACS patients, with a positive correlation.
  • MOTS-c demonstrated high sensitivity (0.890) in predicting unstable angina and myocardial infarction.
  • MOTS-c/TBARS levels predicted MACE in myocardial infarction patients (sensitivity 0.800).
  • In vitro: Oxidative stress induces MOTS-c; MOTS-c treatment reduces hypoxia-induced oxidative stress.

Conclusions:

  • Circulating MOTS-c is associated with increased ACS risk.
  • Imbalance between oxidative stress and MOTS-c may predict MACE in myocardial infarction.
  • MOTS-c represents a potential biomarker for cardiovascular risk assessment.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
758
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
197
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
518